A new qualitative study published in JAMA Network Open examines why people living in states with abortion restrictions may hesitate to use remote medication abortion services, even when they know those options exist. The research focused on 37 individuals who traveled to Kansas to obtain medication abortion in person. Their accounts reveal that awareness alone does not guarantee trust or access: concerns about online drug sources, uncertainty about legal protections, limited knowledge of telehealth services, and a preference for face-to-face medical care all shaped decisions about where and how to seek treatment.
Medication abortion typically involves two medicines. Mifepristone blocks progesterone, a hormone needed to maintain pregnancy, while misoprostol causes uterine contractions that expel pregnancy tissue. When used during early pregnancy under appropriate clinical guidance, the regimen is highly effective and has a well-established safety profile. Care can be provided in a clinic or through telehealth, with medications delivered by mail or collected through a pharmacy, depending on local laws and clinical policies. Yet the study suggests that the practical availability of these services may not translate into perceived availability for patients navigating restrictive legal environments.
Participants described skepticism toward medications obtained through online sources. Some questioned whether websites offering abortion pills were legitimate, whether the products were authentic, and whether the medicines had been stored or shipped correctly. These concerns reflect a central challenge of remote care: patients may not be able to physically identify the clinician, pharmacy, or regulatory system responsible for their treatment. In conventional clinical settings, trust is often reinforced by a visible medical facility, direct conversations with staff, and the presence of established institutional credentials. Online care can make those signals less obvious, particularly for people already worried about safety.
The participants also reported uncertainty about the legal consequences of using remote abortion services. In the United States, abortion regulation varies substantially by state, and the rules governing telehealth, prescribing, mailing medications, clinician licensing, and patient travel can be difficult to interpret. Legal questions may involve not only where a patient is located, but also where a clinician practices, where a prescription is issued, and how medications are distributed. The resulting complexity can create what researchers describe as a “chilling effect,” in which people avoid a potentially lawful health service because they fear investigation, prosecution, or other consequences.
Knowledge gaps further influenced care decisions. Several participants were aware that remote medication abortion existed but did not understand how the process worked, whether they were eligible, how a provider would confirm gestational age, or what would happen if complications developed. In a typical telehealth protocol, clinicians assess medical history, estimate pregnancy duration, screen for conditions such as ectopic pregnancy risk, explain expected symptoms, and provide instructions for follow-up and emergency care. Patients may also be advised to use pregnancy testing or other clinical evaluation to confirm completion. Without clear information about these steps, remote abortion may appear less structured or less medically supervised than in-person care.
The preference for in-person treatment was therefore not simply a rejection of technology. For many participants, traveling to Kansas offered reassurance that the care was recognized, supervised, and connected to a physical health facility. An in-person appointment could provide immediate access to trained staff, direct examination when needed, and a clearer sense of accountability. Travel itself, however, can be expensive and difficult. Patients may need to arrange transportation, time away from work, childcare, lodging, and protection from unwanted disclosure. The decision to travel may represent a compromise between confidence in the care model and the financial and logistical burdens imposed by distance.
The study’s findings are especially relevant as medication abortion increasingly intersects with digital health and interstate care. Remote services can reduce geographic barriers and may be particularly important for people who cannot easily reach a clinic. But the researchers argue that expanding availability is not enough. Health systems and policymakers must also explain how remote care operates, distinguish regulated clinical services from unreliable online sellers, and communicate the limits and protections of applicable laws without offering assurances that cannot be guaranteed. Trusted messengers—including clinicians, pharmacies, public health agencies, and community organizations—may be essential for translating complicated medical and legal information into practical guidance.
The research also highlights the difference between technical safety and perceived safety. A treatment can have strong evidence supporting its effectiveness while still appearing risky to patients who cannot verify the source of the medication or understand the legal framework surrounding it. This gap can influence behavior as powerfully as clinical information. Public communication that focuses only on the existence of telehealth abortion may fail if it does not address how patients evaluate authenticity, privacy, follow-up care, and legal exposure. Building trust may require transparent provider credentials, clear medication instructions, accessible support during treatment, and straightforward explanations of what patients should do if symptoms require urgent attention.
Because the study included 37 people who traveled to Kansas for in-person medication abortion, its findings are intended to provide detailed insight rather than statistically represent all abortion seekers. The participants’ experiences nevertheless offer a warning about the limits of awareness campaigns in a fragmented health and legal environment. For remote medication abortion to reach people who could benefit from it, services must be not only available but also understandable, credible, and responsive to patients’ fears. The study concludes that improving uptake will depend on combining evidence-based medical information with trust-building strategies and clearer communication about the rapidly changing legal landscape.
Subject of Research: Perceptions and decision-making surrounding remote medication abortion among individuals traveling from states with abortion restrictions.
Web References: https://doi.org/10.1001/jamanetworkopen.2026.26444
References: Fiastro AE et al., JAMA Network Open, DOI: 10.1001/jamanetworkopen.2026.26444.
Keywords: Abortion; medication abortion; telehealth; remote health care; mifepristone; misoprostol; abortion restrictions; reproductive health; health care access; legal concerns; decision-making.
